|
|
Article: Reports outline life sciences study findings from Federal University.
- Article from:
- Malaria Weekly (Atlanta, GA)
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Current drugs for treating leishmaniasis are still associated with significant toxicity and failure rates. Thus, new effective and less toxic antileishmanial agents are still in need," scientists in Niteroi, Brazil report (see also Life Sciences).
"Herein, we tested a series of sulfonamide 4-methoxychalcone derivatives against L. amazonensis promastigote and amastigote forms to identify its antileishmanial profile against this species compared to L. braziliensis. In addition, we used molecular modeling tools to determine stereoelectronic features that may lead to the antileishmanial profile. Interestingly, all tested compounds were able to affect L. amazonensis ...
Related newspaper, magazine, and journal articles:
|
|
Article: Federal University reports research in life ...
Biotech Week;
October 7, 2009 ;
700+ words
... ... and colleagues, Federal University (see also Life Sciences). The researchers ... F. Navarro, Federal University of Pernambuco ... Brazil, Recife, Life Sciences, Antifungals, Pharmaceuticals, Federal University. This article ...
|
|